Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single-dose study of S-151128 in Japanese healthy adults
jRCT2031230023Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chronic pain comparing S-151128 IV single dose with Placebo IV single dose (2 arms). Primary endpoints: Safety and tolerability, Adverse events and 9 more. Started Apr 2023; status: completed.
02
Drugs
S-151128
03
Conditions
chronic pain
Beyond the preview
Go deeper on jRCT2031230023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230023.